Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study

Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study

A pandemic designated as Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker for the timely prediction of the disease progression in patients. To analyze the inflammatory profi...

Full description

Bibliographic Details
Main Authors: Yalan Yu, Tao Liu, Liang Shao, Xinyi Li, Colin K. He, Muhammad Jamal, Yi Luo, Yingying Wang, Yanan Liu, Yufeng Shang, Yunbao Pan, Xinghuan Wang, Fuling Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Virulence
Subjects:
covid-19
serum amyloid a protein
disease progression
risk factor
predictor
biomarker
Online Access:http://dx.doi.org/10.1080/21505594.2020.1840108

Internet

http://dx.doi.org/10.1080/21505594.2020.1840108

Similar Items